Dr. Phil Wolfson on MDMA for Terminal Illness

Dr. Phil Wolfson earned his BA at Brandeis University. He went on to graduate school at New York University School of Medicine and began practicing psychotherapy and psychiatry in California between 1966 and 1972. He's licensed to practice medicine in California and Washington. Dr. Wolfson’s been an assistant clinical professor of psychiatry at the University of California San Francisco and has taught at several graduate schools. He was one of the founding members of the Heffter Research Institute, which is another psychedelic research organization, with MAPS, the Multidisciplinary Association for Psychedelic Studies.

Dr. Wolfson is Principal Investigator of a double-blind, placebo-controlled Phase 2 study, located in Marin, California, which will gather preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with a life-threatening illness. The study has received coverage in the San Francisco Chronicle, and KQED Radio on Forum with Michael Krasny, and is poised to be a game-changer in terms of bringing mainstream attention to the topic of psychedelic medicines.